-

CALL US AT

( +1 ) 877-441-4866


Get a Call from us

call-icon

Personalized Medicine Market

  • Personalized medicine market is estimated to reach a market value of USD 3,784.43 million by 2025 with the market growing at a CAGR of 11.42% in the forecasted period 2018-2025.
  • Personalized medicine is an approach connecting the use of individual genetic and epigenetic information to customize the drug therapy. Companies are focusing on developing and identifying effective methods to capture value for innovation in the current regulatory and reimbursement landscape.

Market Dynamics

Drivers

  • Raising prevalence of cancer, growing number of drugs with companion associated diagnostics, use of advanced diagnostic techniques for screening and risk identification, and increasing usage of biomarkers for cancer therapy are some of the major factors driving the growth of the market.
  • Lack of intellectual property regulations for personalized medicine technologies, non-structural development of biomarkers, and lack of proper reimbursement policies are the primary factors restraining the growth of the market.

Segmentation by Product Type

  • The personalized medicine market by product type is segmented into diagnostics, therapeutics, medical care, and nutrition and wellness segments.
  • The diagnostic test is estimated to influence 70% of the decisions made by physicians in the United States with less than 2% being spent on diagnostics signifying a significant potential for the personalized medicine market. Many of the companies were not successful in capturing the market majorly due to the high price of the tests, but companies are focusing on developing low-cost tests which would significantly increase the demand.
  • It is estimated that 30-40% of the novel drugs in the pipeline are being developed in conjunction with a biomarker making this relevant to the treatment of diseases.

Segmentation by Geography

  • The personalized medicine market is segmented into North America, Asia-Pacific, Europe, South America, and others. North America accounted for the most significant market share in 2017 and is forecasted to continue its dominance by the end of the predicted period of 2025.
  • The market access in the Europe and Asia-Pacific region is very challenging due to the highly subsidized prices in these regions. France is an exception in the European area with the presence of grants for advanced molecular testing.
  • There are decidedly fewer reimbursement policies in the Asia-Pacific regions with patients bearing all the expenses restraining the growth of the market in the Asia-Pacific region.
  • Specialized tests such as Selzentry used as a single lab test, whereas the extensive blood tests such as cytochrome p450 are conducting lab tests in more than 5,000 labs in the United States.

Competitive Landscape

  • Companies in the personalized medicine market are focusing on partnering with multiple companies and are focusing on developing diagnostic companies with oncology being the primary area of focus for the major companies in the industry.
  • The major companies in the industry are investing around 3-4% of their R & D spending on the biomarkers while small companies are investing approximately 0.5% of their R & D spend.

The scope of the Report

By Product Type

  • PM Diagnostics
  • Genetic Testing
  • Direct to consumer diagnostics
  • Esoteric lab services
  • Esoteric lab tests
  • PM Therapeutics
  • Pharmaceuticals
  • Genomic medicine
  • Medical devices
  • Personalized nutrition & wellness
  • Retail diet
  • Complementary medicine
  • Alternative medicine
  • Personalized medical care
  • Telemedicine
  • Health information technology
  • Disease Management

Geography

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Rest of the World
  • The report also covers the key factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.

Why Purchase the Report?

  •  Visualize the composition of the Global personalized medicine market with a clear distinction between each design type and usage type.
  •  Identify commercial opportunities in the Global customized medicine Market analyzing trends and co-development deals.
  •  Excel data sheet with thousands of data points in the Global customized medicine market.
  •  PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  •  Product mapping in excel for the principal products of all major market players

Target Audience:

  •  Equipment Suppliers/ Buyers
  •  Service Providers/ Buyers
  •  Industry Investors/Investment Bankers
  •  Education & Research Institutes
  •  Research Professionals
  •  Emerging Companies
  •  Manufacturers

1 : Methodology and Scope

1.1 Research Methodology

1.2 Scope of the report

2: Executive Summary

3: Industry Analysis

3.1 Market Drivers

3.2 Market Restraints

3.3 Porters Five Forces

4: Segmentation by Product Type

4.1 PM Diagnostics

4.1 Genetics Testing

4.2 Direct to consumer diagnostics

4.3 Esoteric lab services

4.4 Esoteric lab tests

4.2 PM Therapeutics

4.2.1 Pharmaceuticals

4.2.2 Genomic medicine

4.2.3 Medical devices

4.3 Personalized nutrition & wellness

4.3.1 Retail nutrition

4.3.2 Complementary medicine

4.3.3 Alternative medicine

4.4 Personalized medical care

4.4.1 Telemedicine

4.4.2 Health information technology

4.4.3 Disease Management

5. Segmentation by Geography

5.1 North America

5.1.1 United States

5.1.2 Canada

5.1.3 Mexico

5.1.4 Rest of North America

5.2 Europe

5.2.1 United Kingdom

5.2.2 Germany

5.2.3 Spain

5.2.4 France

5.2.5 Rest of Europe

5.3 Asia-Pacific

5.3.1 China

5.3.2 Japan

5.3.3 India

5.3.4 Australia

5.3.5 Rest of Asia-Pacific

5.4 South America

5.4.1 Brazil

5.4.2 Argentina

5.4.3 Rest of South America

5.5 Rest of the World

6. Competitive Landscape

6.1 Market Share Analysis

6.2 Key Strategies Adopted by Major companies

7. Company Profiles

7.1 GE Healthcare

7.2 Cepheid

7.3 Asuragen Incorporated

7.4 Illumina Inc

7.5 Abbot Incorporated

7.6 Dako A/s

7.7 Biogen

7.8 Genelex Corp

7.9 Exagen Diagnostics Inc

7.10 Qiagen Inc

7.11 DNA Direct

7.12 Agendia N.V.

8. Appendix

8.1 Sources

8.2 List of Tables

8.3 Expert Panel Validation

8.4 Disclaimer

8.5 Contact Us

Buy This Report



INSTANT DELIVERY - 20% OFF

Could not find what you need?

Quick Fact: 7 of 10 customers Tailor their reports